Companies: 10,795·Total market cap: $144.5T
Immunocore Holdings plc

Immunocore Holdings plc

IMCRNASDAQHealthcare● Active
$27.78
$-0.51(-1.80%)
Market Cap$1.4B
P/E Ratio
52W High$40.715
52W Low$27.555

Immunocore Holdings plc(IMCR)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · IMCR · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.30B$0.25B$0.20B$0.14B$0.03B
Cost of Revenue$0.01B$0.01B$0.00B$0.01B$0.00B
Gross Profit$0.29B$0.24B$0.20B$0.14B$0.03B
Gross Margin %(computed)97.91%97.76%99.58%96.33%100.00%
Operating Expenses
R&D Expenses$0.20B$0.18B$0.13B$0.08B$0.07B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.33B$0.30B$0.24B$0.18B$0.16B
Operating Income($0.03B)($0.06B)($0.05B)($0.04B)($0.13B)
Operating Margin %(computed)-11.34%-22.70%-23.91%-29.66%-478.53%
Interest Income$0.02B$0.03B$0.01B$0.00B$0.00B
Interest Expense$0.01B$0.02B$0.00B$0.01B$0.01B
Income Before Tax($0.01B)($0.04B)($0.05B)($0.03B)($0.13B)
Income Tax Expense$0.01B($0.00B)($0.00B)$0.01B$0.00B
Net Income($0.03B)($0.04B)($0.04B)($0.04B)($0.13B)
Net Margin %(computed)-8.88%-16.45%-22.17%-30.13%-493.45%
Per Share & EBITDA
EPS (Basic)$-0.53$-1.02$-0.89$-0.95$-3.13
Wtd Avg Shares0.05B0.05B0.05B0.05B0.04B
EBITDA$0.00B($0.04B)($0.04B)($0.04B)($0.12B)
EBITDA Margin %(computed)0.13%-15.53%-20.71%-26.59%-456.95%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Immunocore Holdings plc

关于Immunocore Holdings plc(IMCR)损益表

Immunocore Holdings plc(IMCR)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,IMCR实现营收$0.30B,毛利润$0.29B(毛利率97.91%),净利润($0.03B)(净利率-8.88%)。

常见问题

IMCR · 4 问

Immunocore Holdings plc(IMCR)2025财年营收为$0.30B,同比up20.0%。

IMCR revenueIMCR salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08